Evidence that CHD5 functions as a tumor suppressor in human cancer has principally come from studies of neuroblastoma, in which CHD5 mRNA expression was down-regulated likely through promoter methylation in tumors, and high expression of CHD5 was statistically associated with better patient survival [7]. Here, CHD5 is linked to neoplasm.